The Express Gene™ Gender Reveal Test allows expecting parents to determine the gender of their baby early in pregnancy. This non-invasive test analyzes fetal DNA in the mother’s blood, providing reliable results as early as 5 weeks gestation.
Learn your baby’s gender as early as 5 weeks into pregnancy, allowing for early planning and bonding.
The test uses a simple blood sample from the mother, ensuring safety for both mother and baby without any invasive procedures.
Benefit from high accuracy in gender determination, reducing uncertainty and providing clear information.
Explore the Genetic Markers Included in Our Cancer Genetic Testing Panel
ACP5, ADA2, ADAM17, ADAR, AP1S3, ASAH1, CARD14, COPA, DDX58, ELANE, HAX1, HTR1A, IFIH1, IL10RA, IL10RB, IL1RN, IL36RN, ISG15, LPIN2, MEFV, MVK, NLRC4, NLRP1, NLRP12, NLRP3, NOD2, OTULIN, PIK3CD, PIK3R1, PLCG2, POLA1, POMP, PRG4, PRKCD, PSENEN, PSMA3, PSMB4, PSMB8, PSMG2, PSTPIP1, RBCK1, RIPK1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, SH3BP2, SLC29A3, TMEM173, TNFAIP3, TNFRSF11A, TNFRSF1A, TREX1, TRNT1, USP18, WDR1
You can browse through our offerings and find the most suitable test for your needs right from the comfort of your own home.
Once you've selected the appropriate test, we'll provide you with a sample collection kit along with clear instructions on how to collect your sample
Our team of professionals will analyze your sample using state-of-the-art technology and advanced testing methods.
Once the analysis is complete, you'll receive your test results along with a detailed report outlining any genetic predispositions or risk factors identified.
© 2024 ExpressGene. All rights reserved. Unless otherwise indicated, all product names, service names, and logos featured on this website are trademarks owned by ExpressGene, its subsidiaries, or its affiliates. Any use of ExpressGene trademarks, trade names, or trade dress on this website must be authorized in writing by ExpressGene, except for the purpose of identifying ExpressGene’s products or services.